Peter Breuer
Bonn, NW 53127, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Spinocerebellar Ataxia Type 3 Pathophysiology-Implications for Translational Research and Clinical Studies.
Journal: International journal of molecular sciences
Published: February 14, 2024
Aggregation-resistant alpha-synuclein tetramers are reduced in the blood of Parkinson's patients.
Journal: EMBO molecular medicine
Published: February 05, 2024
Downregulation of MGMT expression by targeted editing of DNA methylation enhances temozolomide sensitivity in glioblastoma.
Journal: Neoplasia (New York, N.Y.)
Published: June 16, 2023
The Ratio of Expanded to Normal Ataxin 3 in Peripheral Blood Mononuclear Cells Correlates with the Age at Onset in Spinocerebellar Ataxia Type 3.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: October 27, 2021
Development and validation of a disease-specific quality of life questionnaire for patients with peripheral artery disease (QOLPAD).
Journal: Journal of patient-reported outcomes
Published: July 16, 2021
Hexosamine Pathway Activation Improves Protein Homeostasis through the Integrated Stress Response.
Journal: iScience
Published: April 23, 2019
Development and validation of the Patient Benefit Index for peripheral arterial disease.
Journal: VASA. Zeitschrift fur Gefasskrankheiten
Published: January 26, 2018
DJ-1 is a redox sensitive adapter protein for high molecular weight complexes involved in regulation of catecholamine homeostasis.
Journal: Human molecular genetics
Published: January 09, 2018
DJ-1 is a redox sensitive adapter protein for high molecular weight complexes involved in regulation of catecholamine homeostasis.
Journal: Human molecular genetics
Published: May 24, 2017
Calpain-mediated ataxin-3 cleavage in the molecular pathogenesis of spinocerebellar ataxia type 3 (SCA3).
Journal: Human molecular genetics
Published: October 27, 2012
Last Updated: 09/26/2026